This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

James J. Burke II; Paul M. Fischer, MD

JAMA. 1988;259(23):3444-3448.

Abstract
The office laboratory has the potential to be an ideal setting for cholesterol testing if accurate test results are achieved. This study describes the performance of three office chemistry analyzers (Abbott Vision, Boehringer-Mannheim Reflotron, and Kodak Ektachem DT60 Analyzer) in the measurement of cholesterol. The accuracy of these instruments was assessed by testing aliquots of 84 plasma specimens and comparing these results with values obtained in one of the National Heart, Lung, and Blood Institute's Lipid Research Clinic laboratories. To evaluate instrument precision, results from each of the three instruments were compared with the cholesterol standards recently released by the College of American Pathologists. When operated according to the manufacturers' recommended procedures, each of the three instruments demonstrated analytic capabilities that met the current accuracy and precision goals established by the National Cholesterol Education Program. Analytic issues that are pertinent to the clinician's role as both the office laboratory director and the test interpreter are reviewed.

(JAMA 1988;259:3444-3448)

Author Affiliations
From the Department of Family Medicine, Medical College of Georgia, Augusta.

Footnotes
Reprint requests to the Department of Family Medicine, Medical College of Georgia, 1423 Harper St, Augusta, GA 30912 (Dr Fischer).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Improvements in Heart Health Behaviors and Reduction in Coronary Artery Disease Risk Factors in Urban Teenaged Girls Through a School-Based Intervention: The PATH Program
Bayne-Smith et al.
AJPH 2004;94:1538-1543.
ABSTRACT | FULL TEXT  

A Quality Assurance Program for the Measurement of Capillary Blood Cholesterol Levels in Private Pediatric Practices: The Children's Health Project
Bennett et al.
Arch Pediatr Adolesc Med 1993;147:340-345.
ABSTRACT  

Lipoprotein Profiles in Hypercholesterolemic Children
Garcia and Moodie
Arch Pediatr Adolesc Med 1991;145:147-150.
ABSTRACT  

Impact of a Public Cholesterol Screening Program
Fischer et al.
Arch Intern Med 1990;150:2567-2572.
ABSTRACT  

Portable Cholesterol Analyzers
Furst
JAMA 1990;264:1101-1101.
ABSTRACT  

A Public Health Model for Cardiovascular Risk Reduction: Impact of Cholesterol Screening With Brief Nonphysician Counseling
Gemson et al.
Arch Intern Med 1990;150:985-989.
ABSTRACT  

The Accuracy of Portable Cholesterol Analyzers in Public Screening Programs
Naughton et al.
JAMA 1990;263:1213-1217.
ABSTRACT  

How Reliably Can Compact Chemistry Analyzers Measure Lipids?
Kaufman et al.
JAMA 1990;263:1245-1249.
ABSTRACT  

Screening Asymptomatic Adults for Cardiac Risk Factors: The Serum Cholesterol Level
Garber et al.
ANN INTERN MED 1989;110:622-639.
ABSTRACT  

The Place of HDL in Cholesterol Management: A Perspective From the National Cholesterol Education Program
Grundy et al.
Arch Intern Med 1989;149:505-510.
ABSTRACT  

The Office Measurement of Cholesterol
Boerma
JAMA 1989;261:382-382.
ABSTRACT